Case Report
In September 1992 a 47-year-old Saudi male from Hail was referred from Jeddah to the Gastroenterology Department, Riyadh Armed Forces Hospital (RAFH). He presented with a five month history of abdominal discomfort mainly in the epigastrium, progressive dysphagia, weight loss (about 10 kg) and recent history of melena.
Physical examination was unremarkable except for mild tenderness in the epigastrium. Hematological and biochemical results were within normal limits. Barium swallow revealed a large polypoid lesion at the most distal part of the esophagus, cardia and probably fundus of the stomach ( Figure 1) .
Gastroscopic examination showed a small submucosal spot at 30 cm, multiple dark spots at 35 cm, stricture of cardia, a mass hanging from the cardia in the fundus, dark in color, which bled easily ( Figure 2 ). Multiple biopsies were taken. Histologically malignant melanoma was proven from all biopsies; even the small spots at mid esophagus showed the presence of melanoma (Figure 3 ).
Computed tomography (CT) of the chest and abdomen revealed no evidence of mediastinal, hilar or para-aortic lymphadenopathy. Spleen, kidneys and liver were normal ( Figure 4 ).
Biopsy from a mole on the left cheek showed intradermal nevus. No other lesions were found and diagnosis of primary malignant melanoma of the esophagus was established.
In view of the extent of the lesion, we recommended total esophagectomy and management in a center with special interest and expertise in esophageal surgery. Subsequently, the patient had a total esophagectomy in Germany, with final diagnosis of primary malignant melanoma of the esophagus. Six months following surgery, we were informed that the patient died in Germany due to extensive metastases to the lungs and abdomen as a natural course of primary malignant melanoma of the esophagus, as it is a highly malignant tumor and the prognosis is very poor.
Discussion
Baur1 described primary malignant melanoma of the esophagus in 1906. However, in 1952, Garfinkle and Cahan2 reported the first case, although its existence was doubted since melanocytes had not been identified within the esophageal wall. When De La Pava et al. 3 showed typical melanoblasts in four out of 100 esophagi from necropsy materials, the diagnosis was accepted in 1992.
It is a rare tumor4 accounting for only 0.1% to 0.2% of all esophageal tumors. 5 Male to female ratio is 2: l 9 and it generally occurs from the fifth decade onward, although one case has been reported in a seven-year-old child.13 In our department, this is the only case diagnosed out of more than 200 cases of esophageal carcinoma.
The origin of such a tumor remains largely speculative. Four percent of the normal population showed melanocytes in the epidermal basal layer of the esophagus3 so it has been suggested that the tumor arises within ectopic melanocyte precursors that migrate down the upper two-thirds of the esophagus during development. In 25% of affected cases, melanosis of the esophagus is present.1011 It could be a predisposing factor.
Common presenting symptoms are dysphagia, loss of weight, loss of appetite, and abdominal discomfort, mainly retrosternal, although one asymptomatic patient has been reported.12 Average duration of symptoms is three to five months. The most common location of the tumor is middle and lower third of the esophagus.14 Piccone et al. reported the first case involving the entire esophagus.15 However, partial involvement of the esophagus with melanosis is common. 1718 Macroscopically, the typical lesion is a lobulated, firm, black, rounded polypoid tumor mass.4 On touch, it is friable and bleeds easily.16 Smaller "daughter" metastases are common in the mucosa around the main tumor. The tumor in our patient had this typical presentation. Tumor extent is often underestimated on gross examination, as growth and spread occur mainly within the submucosa and, despite the size of a large tumor, they can be covered with intact squamous mucosa. Microscopic criteria established by Raven and Dawson16 in 1964 , based on the proposal of Allen and Spitz,17 suggests that the tumor should have the structure of melanoma containing melanin granules and should arise from an area of junctional change. However, this criteria is met in only 40% of cases reviewed by Kreuser,18 although he suggested that rapid tumor growth may obliterate junctional change. 20 21 Some pathologists still consider all melanomas of the esophagus as metastatic but several facts support the finding that malignant melanoma can arise primarily in the esophagus. This is confirmed as Burnett and St. John19 reviewed 22,000 autopsies at Johns Hopkins, Baltimore, MD, USA and found 25 malignant melanomas at various sites, but they did not find a single metastasis or a primary in the esophagus. Mofatt et al.14 found that the literature contained only two cases of melanoma metastasizing to the esophagus and De La Pava et al.3 demonstrated the presence of melanoblasts and granules in 4% of the population, establishing the presence of cells from which a primary tumor might develop.
When the diagnosis is known or suspected, a thorough physical examination should include other possible primary Annals o f Saudi Medicine, Voi 14, No 4, 1994 sites with special attention to nail beds, soles of feet, scrotum and nasal sinuses. Evidence of meningeal involvement should be sought; rectal, respiratory and funduscopic examinations are essential. Barium swallow will show a large polypoid, lobulated, ulcerating mass. Gastroscopy should be done to see the lesion and to take biopsies, as diagnosis is made histologically. CT should be done to recognize the lesion's size, shape, local spread and lymph node involvement.
Treatment
The treatment is mainly : Surgery -if the lesion appears operable, Raven and Dawson16 recommended partial esophagogastrectomy with esophagogastrostomy. The majority of resected lesions in literature seem to have been treated in this fashion. Radiotherapy -melanoma is considered to be radio resistant.22 However, some authors still advocate postoperative radiotherapy.7 9 Chemotherapy -adjuvant irradiation and chemotherapy have been used but have not improved survival.23 Prognosis -the prognosis is very poor, as it is a highly malignant tumor. Average survival is seven to 12 months. Five year survival is 4.2%.24 A case of primary malignant melanoma of the esophagus in a 40-year-old female who survived 12 years after surgery has been reported from Northern General Hospital, Sheffield, U.K. Our report is the first case to our knowledge of primary melanoma of the esophagus reported from Saudi Arabia. Metastases were not detected; thus, the hope was for a long survival but the patient subsequently died within six months, as average survival is seven to 12 months.
